Danish Pharmaceuticals & Biotech Big Green Snowflakes

Novo Nordisk

Market Cap: DKK 1.3t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

H. Lundbeck

Market Cap: DKK 40.4b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Bavarian Nordic

Market Cap: DKK 16.0b

Develops, manufactures, and supplies life-saving vaccines.

Strategic Partners

Market Cap: DKK 29.2m

Does not have significant operations.

ChemoMetec

Market Cap: DKK 8.5b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

Gubra

Market Cap: DKK 6.4b

A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.

ALK-Abelló

Market Cap: DKK 47.6b

An allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.

BioPorto

Market Cap: DKK 628.8m

An in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the kidney injury in critically ill patients at earlier stage in Denmark, rest of Europe, North America, and Asia.

Genmab

Market Cap: DKK 128.4b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Zealand Pharma

Market Cap: DKK 22.5b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

Stenocare

Market Cap: DKK 41.2m

Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally.

Pharma Equity Group

Market Cap: DKK 102.1m

Through its subsidiary, Reponex Pharmaceuticals A/S, a clinical-stage biopharmaceutical company, develops treatments for diseases that have patient and social impact for which the current therapy is lacking or in need of improvement.